359 related articles for article (PubMed ID: 16024643)
1. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.
Trivedi RN; Almeida KH; Fornsaglio JL; Schamus S; Sobol RW
Cancer Res; 2005 Jul; 65(14):6394-400. PubMed ID: 16024643
[TBL] [Abstract][Full Text] [Related]
2. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.
Trivedi RN; Wang XH; Jelezcova E; Goellner EM; Tang JB; Sobol RW
Mol Pharmacol; 2008 Aug; 74(2):505-16. PubMed ID: 18477668
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide: mechanisms of action, repair and resistance.
Zhang J; Stevens MF; Bradshaw TD
Curr Mol Pharmacol; 2012 Jan; 5(1):102-14. PubMed ID: 22122467
[TBL] [Abstract][Full Text] [Related]
4. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW
Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995
[TBL] [Abstract][Full Text] [Related]
5. BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis.
Kaina B; Ochs K; Grösch S; Fritz G; Lips J; Tomicic M; Dunkern T; Christmann M
Prog Nucleic Acid Res Mol Biol; 2001; 68():41-54. PubMed ID: 11554312
[TBL] [Abstract][Full Text] [Related]
6. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.
Goellner EM; Grimme B; Brown AR; Lin YC; Wang XH; Sugrue KF; Mitchell L; Trivedi RN; Tang JB; Sobol RW
Cancer Res; 2011 Mar; 71(6):2308-17. PubMed ID: 21406402
[TBL] [Abstract][Full Text] [Related]
7. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses.
Sobol RW; Kartalou M; Almeida KH; Joyce DF; Engelward BP; Horton JK; Prasad R; Samson LD; Wilson SH
J Biol Chem; 2003 Oct; 278(41):39951-9. PubMed ID: 12882965
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
[TBL] [Abstract][Full Text] [Related]
9. Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications.
Zhang J; Stevens MF; Laughton CA; Madhusudan S; Bradshaw TD
Oncology; 2010; 78(2):103-14. PubMed ID: 20357518
[TBL] [Abstract][Full Text] [Related]
10. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.
Stachelek GC; Dalal S; Donigan KA; Campisi Hegan D; Sweasy JB; Glazer PM
Cancer Res; 2010 Jan; 70(1):409-17. PubMed ID: 20028873
[TBL] [Abstract][Full Text] [Related]
12. Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress.
Sobol RW; Watson DE; Nakamura J; Yakes FM; Hou E; Horton JK; Ladapo J; Van Houten B; Swenberg JA; Tindall KR; Samson LD; Wilson SH
Proc Natl Acad Sci U S A; 2002 May; 99(10):6860-5. PubMed ID: 11983862
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
Fishel ML; He Y; Smith ML; Kelley MR
Clin Cancer Res; 2007 Jan; 13(1):260-7. PubMed ID: 17200364
[TBL] [Abstract][Full Text] [Related]
14. Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.
Eich M; Roos WP; Dianov GL; Digweed M; Kaina B
Mol Pharmacol; 2010 Nov; 78(5):943-51. PubMed ID: 20729302
[TBL] [Abstract][Full Text] [Related]
15. Triazene compounds: mechanism of action and related DNA repair systems.
Marchesi F; Turriziani M; Tortorelli G; Avvisati G; Torino F; De Vecchis L
Pharmacol Res; 2007 Oct; 56(4):275-87. PubMed ID: 17897837
[TBL] [Abstract][Full Text] [Related]
16. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.
Agnihotri S; Burrell K; Buczkowicz P; Remke M; Golbourn B; Chornenkyy Y; Gajadhar A; Fernandez NA; Clarke ID; Barszczyk MS; Pajovic S; Ternamian C; Head R; Sabha N; Sobol RW; Taylor MD; Rutka JT; Jones C; Dirks PB; Zadeh G; Hawkins C
Cancer Discov; 2014 Oct; 4(10):1198-213. PubMed ID: 25100205
[TBL] [Abstract][Full Text] [Related]
17. Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.
Tentori L; Turriziani M; Franco D; Serafino A; Levati L; Roy R; Bonmassar E; Graziani G
Leukemia; 1999 Jun; 13(6):901-9. PubMed ID: 10360379
[TBL] [Abstract][Full Text] [Related]
18. DNA polymerases beta and lambda mediate overlapping and independent roles in base excision repair in mouse embryonic fibroblasts.
Braithwaite EK; Kedar PS; Stumpo DJ; Bertocci B; Freedman JH; Samson LD; Wilson SH
PLoS One; 2010 Aug; 5(8):e12229. PubMed ID: 20805875
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.
Cai S; Xu Y; Cooper RJ; Ferkowicz MJ; Hartwell JR; Pollok KE; Kelley MR
Cancer Res; 2005 Apr; 65(8):3319-27. PubMed ID: 15833865
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.
Paik J; Duncan T; Lindahl T; Sedgwick B
Cancer Res; 2005 Nov; 65(22):10472-7. PubMed ID: 16288039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
